" /> Spinocerebellar ataxia 2 - CISMeF





Preferred Label : Spinocerebellar ataxia 2;

Symbol : SCA2;

CISMeF acronym : ALS13; OPCA2; SCA2; SDSEM;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Spinocerebellar atrophy II; Olivopontocerebellar atrophy, holguin type; Olivopontocerebellar atrophy II; Spinocerebellar ataxia, cuban type; Cerebellar degeneration with slow eye movements; Wadia-swami syndrome; Spinocerebellar degeneration with slow eye movements; OPCA2; SDSEM;

Included titles and symbols : Amyotrophic lateral sclerosis, susceptibility to, 13; ALS13;

Description : Autosomal dominant cerebellar ataxias (ADCAs) are a heterogeneous group of disorders that were classified clinically by Harding (1983). Progressive cerebellar ataxia is the primary feature. In ADCA I, cerebellar ataxia of gait and limbs is invariably associated with supranuclear ophthalmoplegia, pyramidal or extrapyramidal signs, mild dementia, and peripheral neuropathy. In ADCA II, macular and retinal degeneration are added to the features. ADCA III is a pure form of late-onset cerebellar ataxia. ADCA I includes SCA1 (164400), SCA2, and SCA3, or Machado-Joseph disease (109150). These 3 are characterized at the molecular level by CAG repeat expansions on 6p24-p23, 12q24.1, and 14q32.1, respectively. For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).;

Inheritance : Autosomal dominant;

Molecular basis : Caused by expanded CAG trinucleotide repeats in the ataxin-2 gene (ATX2, 601517.0001).;

Prefixed ID : #183090;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.